Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prednisolone in early psychosis
NCT03340909Phase 2Terminated
- Sponsor
- Haukeland University Hospital
- Start
- Feb 2018
- Primary completion
- Dec 2021
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of prednisolone in schizophrenia spectrum and other psychotic disorders, psychosis, cognitive impairment, sponsored by Haukeland University Hospital. Started Feb 2018; status: terminated.
02
Drugs
prednisolone
03
Conditions
schizophrenia spectrum and other psychotic disorderspsychosiscognitive impairment
Beyond the preview
Go deeper on NCT03340909.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03340909.